CompletedNCT03535077
Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)
Studying Familial atypical multiple mole melanoma syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Orlucent, Inc
- Principal Investigator
- Cathy Shachaf, PhDPresident
- Intervention
- Diagnostic Test(other)
- Enrollment
- 186 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2018 – 2022
Study locations (6)
- Center for Dermatology Clinical Research, Inc, Fremont, California, United States
- UCI Center for Clinical Research, Irvine, California, United States
- Divya Railan, Md, Faad, Menlo Park, California, United States
- Quest Dermatology Research, Northridge, California, United States
- Solano Dermatology Associates, Vallejo, California, United States
- University of Utah, Salt Lake City, Utah, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03535077 on ClinicalTrials.govOther trials for Familial atypical multiple mole melanoma syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06599619Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic NeviJohn Kirkwood
- RECRUITINGNCT04095195Registry of Subjects at Risk of Pancreatic CancerAssociazione Italiana per lo Studio del Pancreas
- RECRUITINGNCT05446155BioMEL- Diagnostic and Prognostic Factors in Melanoma.Region Skane
- RECRUITINGNCT00040352Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of MelanomaNational Cancer Institute (NCI)
See all trials for Familial atypical multiple mole melanoma syndrome →